Skip to main content
. Author manuscript; available in PMC: 2021 Mar 15.
Published in final edited form as: Clin Cancer Res. 2020 Jul 15;26(18):4823–4831. doi: 10.1158/1078-0432.CCR-20-1434

Fig. 3. Cumulative incidence of events stratified by IL6 levels.

Fig. 3.

Events were defined as death from progressive disease or death from toxicity and/or infection after infusion of axi-cel. Patient samples were collected prior to lymphodepleting chemotherapy and stratified by baseline IL6 level ≥ 40pg/mL or <40pg/mL.